Comparative analysis of the immunogenicity of monovalent and multivalent rotavirus immunogens.

The strategies for developing rotavirus (RV) vaccines have always been controversial. At present, both the monovalent RV vaccine and the multivalent RV vaccine have displayed excellent safety and efficacy against RV infection and shown cross-reactive immunity, which laid the question whether the mul...

Full description

Bibliographic Details
Main Authors: Kai Mi, Xia Ou, Lili Guo, Jing Ye, Jinyuan Wu, Shan Yi, Xianglian Niu, Xiaoqin Sun, Hongjun Li, Maosheng Sun
Format: Article
Language:English
Published: Public Library of Science (PLoS) 2017-01-01
Series:PLoS ONE
Online Access:http://europepmc.org/articles/PMC5313208?pdf=render
_version_ 1819263867637727232
author Kai Mi
Xia Ou
Lili Guo
Jing Ye
Jinyuan Wu
Shan Yi
Xianglian Niu
Xiaoqin Sun
Hongjun Li
Maosheng Sun
author_facet Kai Mi
Xia Ou
Lili Guo
Jing Ye
Jinyuan Wu
Shan Yi
Xianglian Niu
Xiaoqin Sun
Hongjun Li
Maosheng Sun
author_sort Kai Mi
collection DOAJ
description The strategies for developing rotavirus (RV) vaccines have always been controversial. At present, both the monovalent RV vaccine and the multivalent RV vaccine have displayed excellent safety and efficacy against RV infection and shown cross-reactive immunity, which laid the question whether the multivalent RV vaccine could be replaced by the monovalent RV vaccine. In this study, we focused on comparing the immunogenicity (serum neutralization activity and protection against homotypic and heterotypic RVs' challenge) of individual standard RV strains (monovalent RV immunogens) and different combinations of them (multivalent RV immunogens). In result, RV immunogens showed general immunogenicity and heterotypic reaction but the multivalent RV immunogens exhibited greater serum neutralization activity and stronger heterotypic reaction than the monovalent RV immunogens (P<0.05). As to the protection, the multivalent RV immunogens also revealed more rapid and stronger protection against homotypic and heterotypic RVs' challenge than the monovalent RV immunogens. The results demonstrated that both the monovalent and multivalent RV immunogens exhibited high immunogenicity, but the monovalent RV immunogens could not provide enough neutralization antibodies to protect MA104 cells against the infection with heterotypic RV strains and timely protection against homotypic and heterotypic RVs, so the multivalent RV vaccine could not be replaced by the monovalent RV vaccine.
first_indexed 2024-12-23T20:20:25Z
format Article
id doaj.art-4143b05806f84858b77f1f71309839de
institution Directory Open Access Journal
issn 1932-6203
language English
last_indexed 2024-12-23T20:20:25Z
publishDate 2017-01-01
publisher Public Library of Science (PLoS)
record_format Article
series PLoS ONE
spelling doaj.art-4143b05806f84858b77f1f71309839de2022-12-21T17:32:33ZengPublic Library of Science (PLoS)PLoS ONE1932-62032017-01-01122e017215610.1371/journal.pone.0172156Comparative analysis of the immunogenicity of monovalent and multivalent rotavirus immunogens.Kai MiXia OuLili GuoJing YeJinyuan WuShan YiXianglian NiuXiaoqin SunHongjun LiMaosheng SunThe strategies for developing rotavirus (RV) vaccines have always been controversial. At present, both the monovalent RV vaccine and the multivalent RV vaccine have displayed excellent safety and efficacy against RV infection and shown cross-reactive immunity, which laid the question whether the multivalent RV vaccine could be replaced by the monovalent RV vaccine. In this study, we focused on comparing the immunogenicity (serum neutralization activity and protection against homotypic and heterotypic RVs' challenge) of individual standard RV strains (monovalent RV immunogens) and different combinations of them (multivalent RV immunogens). In result, RV immunogens showed general immunogenicity and heterotypic reaction but the multivalent RV immunogens exhibited greater serum neutralization activity and stronger heterotypic reaction than the monovalent RV immunogens (P<0.05). As to the protection, the multivalent RV immunogens also revealed more rapid and stronger protection against homotypic and heterotypic RVs' challenge than the monovalent RV immunogens. The results demonstrated that both the monovalent and multivalent RV immunogens exhibited high immunogenicity, but the monovalent RV immunogens could not provide enough neutralization antibodies to protect MA104 cells against the infection with heterotypic RV strains and timely protection against homotypic and heterotypic RVs, so the multivalent RV vaccine could not be replaced by the monovalent RV vaccine.http://europepmc.org/articles/PMC5313208?pdf=render
spellingShingle Kai Mi
Xia Ou
Lili Guo
Jing Ye
Jinyuan Wu
Shan Yi
Xianglian Niu
Xiaoqin Sun
Hongjun Li
Maosheng Sun
Comparative analysis of the immunogenicity of monovalent and multivalent rotavirus immunogens.
PLoS ONE
title Comparative analysis of the immunogenicity of monovalent and multivalent rotavirus immunogens.
title_full Comparative analysis of the immunogenicity of monovalent and multivalent rotavirus immunogens.
title_fullStr Comparative analysis of the immunogenicity of monovalent and multivalent rotavirus immunogens.
title_full_unstemmed Comparative analysis of the immunogenicity of monovalent and multivalent rotavirus immunogens.
title_short Comparative analysis of the immunogenicity of monovalent and multivalent rotavirus immunogens.
title_sort comparative analysis of the immunogenicity of monovalent and multivalent rotavirus immunogens
url http://europepmc.org/articles/PMC5313208?pdf=render
work_keys_str_mv AT kaimi comparativeanalysisoftheimmunogenicityofmonovalentandmultivalentrotavirusimmunogens
AT xiaou comparativeanalysisoftheimmunogenicityofmonovalentandmultivalentrotavirusimmunogens
AT liliguo comparativeanalysisoftheimmunogenicityofmonovalentandmultivalentrotavirusimmunogens
AT jingye comparativeanalysisoftheimmunogenicityofmonovalentandmultivalentrotavirusimmunogens
AT jinyuanwu comparativeanalysisoftheimmunogenicityofmonovalentandmultivalentrotavirusimmunogens
AT shanyi comparativeanalysisoftheimmunogenicityofmonovalentandmultivalentrotavirusimmunogens
AT xianglianniu comparativeanalysisoftheimmunogenicityofmonovalentandmultivalentrotavirusimmunogens
AT xiaoqinsun comparativeanalysisoftheimmunogenicityofmonovalentandmultivalentrotavirusimmunogens
AT hongjunli comparativeanalysisoftheimmunogenicityofmonovalentandmultivalentrotavirusimmunogens
AT maoshengsun comparativeanalysisoftheimmunogenicityofmonovalentandmultivalentrotavirusimmunogens